• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alnylam Pharmaceuticals Inc

+ Add to Watchlist

ALNY:US

57.3600 USD 0.4900 0.85%

As of 20:10:00 ET on 07/11/2014.

Company Profile for Alnylam Pharmaceuticals Inc (ALNY)

Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.

Contact Information

Alnylam Pharmaceuticals Inc

300 Third Steet
Cambridge, MA 02142
United States
Phone: 1-617-551-8200
Fax: 1-617-551-8101

Key Executives for Alnylam Pharmaceuticals Inc (ALNY)

John M MaraganoreChief Executive OfficerBarry E GreenePresident/COO
Akshay K VaishnawExec VP/Chief Medical OfficerLaurence E ReidSenior VP/Chief Business Ofcr
Michael P MasonVP:Finance/TreasurerCynthia ClaytonVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil